F. Hoffmann-La Roche Ltd, Siemens and Abbott are dominating the Asia-Pacific Lab Automation Market in 2018

Asia-Pacific Lab Automation Market is expected to grow at a substantial CAGR in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:

Access Full Report at https://www.databridgemarketresearch.com/reports/asia-pacific-lab-automation-market

Asia-Pacific lab automation market is an upcoming market which includes key players and local players. The market is growing owing to the favourable market scenario. The market has a prominent growth in upcoming years due to increase in R&D expenditure by pharmaceutical and biopharmaceutical companies and increasing geriatric population.

The market has witnessed developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand of marine ingredients. For instance, In July 2019, Agilent Technologies, Inc. has acquired BioTek in the cell segment. The acquisition has helped in providing cost effective analysis with diverse applications enabling the various researches of life sciences for the customers and the clients globally.

F. Hoffmann-La Roche Ltd dominated the Asia-Pacific lab automation market. The other key players existing in the market are Siemens, Abbott, Agilent Technologies, Inc., Danaher, BD, PerkinElmer Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Brooks Automation, Inc., Hamilton Company, Hudson Robotics, LabWare, Thermo Fisher Scientific Inc. among others.

F. Hoffmann-La Roche Ltd:

F. Hoffmann-La Roche Ltd is a public company which is headquartered in Basel, Switzerland and was founded in 1896. The company is specialized in offering drugs and in-vitro diagnostics for the transplantation as well as for cancer. The company operates through two business segment which include pharmaceuticals, diagnostics in which pharmaceuticals is the market focused segment. The products categories of this company include diabetes care, digital diagnostics, donor screening, laboratory automation & software solutions, microbiology, molecular diagnostics, point of care, urinalysis in which laboratory automation & software solutions is the market focused category. The company has approx. 94,442 employees.

  • In January 2019, F. Hoffmann-La Roche Ltd announced the launch of Cobas pro integrated solutions which is available in countries that embrace the CE label. With this launch, the company will expand its product portfolio as well as augment the market size which will help to grow the revenue of the company.

The company has its global presence in Europe, North America, Latin America, Asia-pacific and Middle East & Africa. Subsidiaries of this company include Genentech, Inc. (U.S.), Roche Diagnostics Limited (U.K.), Chugai Pharmaceutical Co. (Japan), Flatiron Health, Inc. (U.S.), Ventana Medical Systems (U.S.), Kapa Biosystems, Inc. (U.S.) among others.


Siemens is a public company which is headquartered in Munich, Germany and was founded in 1847. The company focuses on electrification, automation and digitalization and even provides solution for power generation, transmission and medical diagnostics. The company mainly manages their operation in Siemens Healthineers, digital factory, power and gas, energy management, Siemens Gamesa renewable energy, process industries and drives, mobility, building technologies. The market focus business segment lies under Siemens Healthineers. The products categories of this company include building technologies, energy, drive technology, financing, healthcare, automation, mobility, services, software, consumer products in which healthcare is the market focused category. The company has approx. 379,000 employees as of 30th September, 2018.

  • In September 2017, Siemens Healthcare Private Limited launched the commercial availability and CE mark chemistry analysers. The launch helped in providing sample management and flexibility in the labs to help the customers to maintain better outcomes and focus on better business proceedings.

The company has its global presence in North America, Asia-Pacific, Europe, Middle East and Africa, Latin America. Subsidiaries of this company include AD 8MW GmbH & Co. KG (Germany), Adwen Blades GmbH (Germany), Adwen GmbH (Germany), Adwen Verwaltungs GmbH (Germany), Airport Munich Logistics and Services GmbH (Germany), Flowmaster GmbH (Germany), HSP Hochspannungsgeräte GmbH (Germany) and many others.


Abbott is a public company which is headquartered in Illinois, U.S. and was founded in 1888. The company deals in manufacturing diagnostics, medical devices, nutrition and branded generic pharmaceuticals products. The company operates through five business segment which include established pharmaceuticals, nutritionals, diagnostics, cardiovascular and neuromodulation, other in which diagnostics is the market focused segment. The brand categories of this company include GLP systems, accelerator, architect, CELL-DYN, Alinity, Aliniq in which GLP Systems and accelerator are the market focused categories. The company has approx. 103,000 employees as of December 31, 2018.

  • In June 2019, Abbott acquired 85% equity stake in GLP Systems GmbH (Germany), a subsidiary of Sonic Healthcare Limited. GLP has established its laboratory automation system in eight Sonic laboratories located in Australia, the United Kingdom and Germany. With this equity acquisition, company will expand its business as well as product portfolio which further help to grow sales and revenue of the company.

The company has its global presence in Americas, Asia-Pacific, Europe, Middle East and South Africa. Subsidiaries of this company include Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd (India), Thoratec Corporation (U.S.), Abbott Informatics (U.S.), CardioMEMS (U.S.), CFR Pharmaceuticals (Chile), Abbott GmbH & Co. KG (Germany) among others.